Document is current
Any future updates will be listed below
-
Authors
Blacher, Jacques https://orcid.org/0000-0003-4860-4279
Kab, Sofiane
Cheddani, Lynda
Halimi, Jean-Michel
Stengel, Bénédicte
De Pinho, Natalia Alencar
Goldberg, Marcel
Zins, Marie
Olié, Valérie
-
Funding
Funding for this research was provided by:
Caisse Nationale d’Assurance Maladie
Ministère des Affaires Sociales et de la Santé
Ministère de l'Enseignement Supérieur et de la Recherche
Institut National de la Santé et de la Recherche Médicale
- License Information
-
More Information
Article History
Received: 26 February 2025
Accepted: 27 May 2025
First Online: 1 July 2025
Declarations
:
: All procedures performed in the Constances study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The National Data Protection Authority and the Institutional Review Board of the National Institute for Medical Research and the local Committee for Persons Protection approved the Constances study. All participants signed an informed consent to participate to the Constances epidemiologic cohort.
: Not applicable.
: JB reports, outside the submitted work, personal fees and/or non-financial support from AstraZeneca, Bayer, Elkendi, Hikma, Leurquin, Omron, Organon, Sanofi, ViiV, Vivactis and Vivoptim. JMH reports, outside the submitted work, personal fees and/or non-financial support from Ablynx, Alexion, AstraZeneca Rare Disease, AstraZeneca, Bayer, Bouchara-Recordati, Fresenius, GlaxoSmithKline, Mundipharma, Merck Sharp & Dohme, Roche, Servier, Sanofi, and Vifor Fresenius. The other authors have no conflict of interest.
